Daiichi Sankyo appoints new CEO
PARSIPPANY, N.J. — Daiichi Sankyo’s SVP commercial operations has taken on a new role at the company.
The drug maker said that John Gargiulo would become president and CEO, effective Monday, following the retirement of current leader Joseph Pieroni.
Gargiulo has been with Daiichi Sankyo since its inception in 1996. In addition to his role at the company, he currently serves on the board of directors of the Pharmaceutical Research and Manufacturers Association, as well as the National Pharmaceutical Council.
"I am excited about leading DSI through our next company milestones and fostering a continuing vision of employee excellence that will drive DSI growth and success," Gargiulo said.
Jaeger resigns from CEO post at NCPA
ALEXANDRIA, Va. — Just four months after being appointed EVP and CEO of the National Community Pharmacists Association, Kathleen Jaeger is making an exit.
The NCPA said that Jaeger will be leaving the organization to pursue other opportunities. Effective immediately, Douglas Hoey, who has served as NCPA’s COO since 2005, will assume the chief executive role.
Commenting on the executive change, NCPA president Robert Greenwood said Jaeger brought "many talents and ideas to NCPA" and wished her luck on her future endeavors. Greenwood added that Hoey "has dedicated his career to advancing the ability of community pharmacists to effectively care for their patients."
Responding to his appointment, Hoey said, "I am excited and honored to lead this outstanding organization. And I am humbled by the trust that NCPA’s executive committee has placed in me," Hoey said. "Community pharmacists play a critical, and growing, role in today’s healthcare system. They provide trusted medication counseling, adherence services, patient care and other cost-saving services to millions of Americans."
Walmart further emphasizes pharmacy, health services with Lewis hire
WHAT IT MEANS AND WHY IT’S IMPORTANT — Walmart’s hiring of Dijuana Lewis is yet another sign the company no longer is content being a fast-follower when it comes to its pharmacy and healthcare businesses, whereas a decade ago, Walmart’s emphasis was on simply operating pharmacies, filling as many prescriptions as possible and keeping up with chain drug leaders who were setting the pace in terms of innovative programs.
(THE NEWS: Healthcare exec joins Walmart. For the full story, click here.)
These days, it’s more about developing innovative programs and finding new ways to extend its reach into pharmacy and health services that align with the company’s value proposition of helping people save money so they can live better.
Lewis’ background and accomplishments at Wellpoint suggest she is ideally suited for Walmart. The Indiana native spent 16 years at the healthcare company holding a variety of roles, but what stands out is the fact that many of those roles were focused on improving efficiency, reducing costs and delivering an improved experience for customers. Sounds like an ideal fit for Walmart, as the company looks to play a bigger role in influencing the nation’s healthcare delivery system and then profiting from those changes.